GET DAILY SIGNALSBritish American Tobacco (BTI) Delivers Steady H1 2026 Growth with +2.9% Revenue and +7.9% EPS
Key Takeaways
- British American Tobacco reported its first-half 2026 (H1 2026) results on July 30, 2026, with group revenue up 2.9% on a constant-currency basis.
- Adjusted diluted earnings per share (EPS, a measure of profit attributable to each share) rose 7.9%, supported by lower net finance costs and strong cash conversion.
- New Category revenue climbed 18%, led by a 66% surge in Modern Oral nicotine products such as Velo.
- Smoke-free products reached 19.8% of group revenue, up 160 basis points, as the company added 4.1 million smokeless consumers to reach 35 million in total.
- Management raised full-year EPS guidance to the middle of its 5%–8% growth range while expecting revenue and operating profit near the lower end.
- For more context, explore Major News, Today's Price Move, Price Targets, and Forecast on Tickeron's dedicated BTI pages.
- You can also explore Trending AI Robots to discover automated trading strategies aligned with current market conditions.
Earnings Context and Why It Matters
British American Tobacco's H1 2026 report offers a progress check on its long-running pivot from traditional cigarettes toward a "smokeless" future. The company's New Category portfolio — nicotine pouches, vapour, and heated tobacco — is now central to its growth story, even as combustibles remain the primary cash engine. Investors watch these results closely because they reveal whether the transition is generating genuine profitability rather than simply top-line growth. The first half also carried added significance following a December 2025 trading update and a string of regulatory developments in key markets such as the United States. I also checked this using Tickeron’s AI Screener to see how BTI compares to others in the industry.
Reported Results
For the six months ended June 30, 2026, British American Tobacco delivered results in line with management's own expectations on a constant-currency basis. Group revenue rose 2.9%, while adjusted diluted EPS increased 7.9%. Adjusted operating profit grew 3.5%, and the group's operating margin expanded by 30 basis points to 43.7%, reflecting stronger New Category profitability and ongoing cost savings.
New Category revenue increased 18%, with Modern Oral (nicotine pouches) up 66%, driven by the continued success of the Velo brand, including Velo Plus. Vapour revenue rose 5.3%, supported by a recovering U.S. market, while heated products lagged as glo revenue declined roughly 12% amid inventory movements and competitive pressure. Combustibles revenue grew 2.1%, helped by strong pricing, even as volumes fell 4.7%.
Management raised its full-year EPS outlook to the middle of the 5%–8% guidance range while signaling that revenue and operating profit would land near the lower end of their ranges, partly reflecting a roughly 1% transactional foreign-exchange headwind.
Market Reaction and Investor Sentiment
Sentiment around BTI heading into and following the H1 2026 release has been shaped by the company's improving U.S. performance and the accelerating adoption of modern oral products. The results confirmed a return toward management's medium-term growth algorithm, which investors generally viewed as a stabilizing signal. At the same time, lingering concerns over heated-product weakness, slower-than-expected recovery in the Asia-Pacific, Middle East, and Africa (APMEA) region, and competitive pressure in the U.S. discount segment have tempered enthusiasm. The raised EPS outlook and reaffirmed commitment to a progressive dividend and £1.3 billion buyback provided a degree of support for income-focused shareholders.
Forward Outlook and Key Factors to Monitor
Management pointed to a second-half-weighted profit profile, driven by the phasing of New Category investments and the ramp-up of cost-saving initiatives under its Fit2Win program. The company now targets roughly £700 million in annualized savings by 2028, with about £500 million expected by 2027.
Investors should watch whether Modern Oral momentum, particularly Velo and the newly launched Velo Max, continues to accelerate. The phased U.S. rollout of new Vuse vapour flavours and the expansion of heated products such as glo Hilo and Hyper Pro+ will also be important indicators of New Category traction.
On the cost and balance-sheet side, the company expects net finance costs of about £1.65 billion for the year, an underlying tax rate of 24%–25%, and leverage moving toward its 2.0–2.5x adjusted net debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) target. A continued recovery in APMEA and the sustainability of U.S. combustibles pricing remain key swing factors for the second half and into 2027. From what I see, these elements will shape the trajectory in the quarters ahead.
Using AI Tools for Deeper Analysis
In my view, tools like Tickeron’s AI-powered platforms can add valuable perspective when reviewing results like these. I often turn to the AI Screener to scan for comparable names in the consumer staples space and spot technical setups that align with fundamental shifts. It helps surface ideas efficiently without replacing core research, and it has been useful for tracking how names like BTI stack up against peers on metrics such as momentum and volatility.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BTI in +5.90% Uptrend, rising for three consecutive days on October 16, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BTI advanced for three days, in 235 of 374 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on BTI as a result. In 39 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 50%.
The Moving Average Convergence Divergence (MACD) for BTI just turned positive on October 08, 2026. Looking at past instances where BTI's MACD turned positive, the stock continued to rise in 19 of 43 cases over the following month. The odds of a continued upward trend are 44%.
BTI moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BTI crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 38%.
Bearish Trend Analysis
The 10-day RSI Indicator for BTI moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 21 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
BTI broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BTI entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. BTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.660) is normal, around the industry mean (-7.193). P/E Ratio (20.444) is within average values for comparable stocks, (12.612). Projected Growth (PEG Ratio) (1.415) is also within normal values, averaging (3.595). Dividend Yield (0.056) settles around the average of (0.060) among similar stocks. P/S Ratio (3.521) is also within normal values, averaging (2.780).
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a retailer of tobacco related products
Industry Tobacco
Advertisement